Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.78 - $1.01 $17,672 - $22,883
-22,657 Reduced 50.13%
22,543 $19,000
Q1 2023

May 12, 2023

SELL
$0.72 - $1.12 $8,064 - $12,544
-11,200 Reduced 19.86%
45,200 $37,000
Q4 2022

Feb 13, 2023

BUY
$0.83 - $8.04 $46,812 - $453,455
56,400 New
56,400 $50,000
Q2 2022

Aug 12, 2022

SELL
$2.21 - $2.7 $40,885 - $49,950
-18,500 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.37 - $3.24 $89,557 - $122,433
-37,788 Reduced 67.13%
18,500 $45,000
Q4 2021

Feb 11, 2022

SELL
$2.92 - $3.76 $247,169 - $318,272
-84,647 Reduced 60.06%
56,288 $171,000
Q3 2021

Nov 12, 2021

SELL
$3.28 - $4.07 $144,533 - $179,344
-44,065 Reduced 23.82%
140,935 $529,000
Q2 2021

Aug 13, 2021

SELL
$3.43 - $3.96 $514,500 - $594,000
-150,000 Reduced 44.78%
185,000 $718,000
Q1 2021

May 13, 2021

BUY
$2.2 - $3.94 $450,766 - $807,282
204,894 Added 157.48%
335,000 $1.3 Million
Q4 2020

Feb 10, 2021

BUY
$1.91 - $2.5 $150,137 - $196,515
78,606 Added 152.63%
130,106 $325,000
Q3 2020

Nov 13, 2020

SELL
$1.96 - $2.92 $56,448 - $84,096
-28,800 Reduced 35.87%
51,500 $114,000
Q2 2020

Aug 13, 2020

BUY
$1.58 - $2.86 $46,294 - $83,798
29,300 Added 57.45%
80,300 $161,000
Q1 2020

May 14, 2020

SELL
$1.43 - $3.23 $76,171 - $172,052
-53,267 Reduced 51.09%
51,000 $82,000
Q4 2019

Feb 13, 2020

BUY
$2.74 - $4.2 $285,691 - $437,921
104,267 New
104,267 $344,000

Others Institutions Holding THTX

# of Institutions
1
Shares Held
29.2K
Call Options Held
0
Put Options Held
0

About Theratechnologies Inc.


  • Ticker THTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,141,600
  • Market Cap $114M
  • Description
  • Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...
More about THTX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.